Posts

cliexa is now available in the athenaHealth Marketplace

Today, cliexa Inc., a thriving producer of mobile health care management services, revealed a partnership with athenahealth, Inc.® through athenahealth’s “More Disruption Please” (MDP) Marketplace program. As an MDP partner, our cross-communication platform developed for chronic pain patients and providers, cliexa-EASE, is now immediately available to athenahealth’s network of 100,000+ providers and countless prospective clients. EASE enables patients and clinicians to make intelligent correlations between medication dosage, frequency and heightened or reduced symptoms by leveraging an application that functions as a pain assessment model for chronic pain management with seamless scalable EMR integration via API and global HL7 connectivity.

cliexa provides the ideal pain management application to leverage patient-reported outcomes to improve treatment decisions and patient experience, while also maximizing compliance and reimbursement. cliexa-EASE is designed for chronic pain management, podiatry, and general patient wellness. cliexa-EASE allows providers to gather digitized intake data and customize assessments to correlate data that best adheres to their patient population.

In order to provide physicians with high accuracy metrics, cliexa-EASE uses patient reporting methods on visual body maps, and pain expression in voice, face, and body movements. This allows physicians to view the physical attributes of pain beyond self-reported descriptions which can often be difficult to translate into clinical diagnostics terms. Tracking these markers allows physicians to use patient-reported outcomes to treat the “whole patient.”  One of cliexa’s existing clients, Anderson Podiatry Center, is already seeing the benefits of using the cliexa platform with a custom digital patient intake and screening process, also digital consent forms, integrated to their athenahealth electronic medical record (EMR).

The athenahealth Marketplace partnership opens up a hyperconnected, national network of healthcare professionals providing chronic pain management. With this partnership, the two companies align to provide measurable financial and clinical results for providers. cliexa is a real-time data provider for future medicine and will continue to build on our vision to increase patient-provider engagement and compliance through mobile health solutions.

“We are excited to partner both with athenahealth and Anderson Podiatry Center to deploy cliexa platform into the marketplace as this is the first of many subspecialties we currently have in our portfolio. We are looking forward to implementing other subspecialty applications to the athenahealth marketplace which will strengthen our partnership in healthcare space,” says Mehmet Kazgan, Founder and CEO of cliexa.

Eric Seyler, CEO of Anderson Podiatry Center, says, “The transition to a digital patient intake has given us more opportunities to help our patients than we had envisioned. Our patients have spent less time in the waiting room with more time delegated to their doctor’s visit. The integration is done in real-time which supports our goal to be more efficient with clinic resources while helping to provide the best possible patient experience.”

cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and documentation through real-time integration to athenahealth electronic medical record, which streamlines processes and increases efficiency in population health management.

View our listing here: //marketplace.athenahealth.com/product/cliexa

cliexa PTSI Press Release

We are proud to announce that we have officially joined forces with Preventative Technology Solutions, who will now become apart of the cliexa family.

Here is the link to the press release about the acquisition: //www.pr.com/press-release/768313

 

Digital health benefits

2018 has seen a significant boom in the application of technology in digital health innovation, which are poised to disrupt the healthcare industry. Innovations have included advances in mobile health (mHealth), health information technology (IT), as well as wearable and Internet-of-Things (IoT) devices.

cliexa has identified six specific areas of medicine already reaping the benefits of digital health innovation:

1. Rheumatology

Disease Activity Scoring (DAS) metrics remotely collected by cliexa from patients are used by physicians in their offices when assessing the severity of rheumatoid arthritis through a Q & A approach. cliexa empowers patients with the ability to communicate their patient-reported outcomes to their physicians at the touch of a finger, on their own mobile devices, providing physicians with instantly-scored clinically-validated assessments. The application of cliexa innovations in rheumatology drastically increases the efficiency and quality-of-care for both patients and their providers.

Check out the cliexa mobile platform for Rheumatoid Arthritis, cliexa-RA: //www.cliexa.com/cliexamobile/rheumatoid-arthritis/

2. Pain Management, Primary Care, & Integrative Medicine

Chronic pain, affecting over 10% of American adults, is a leading cause of opiate abuse. Managing and overcoming chronic pain is a complex obstacle for many healthcare providers. With the increased shift away from the prescribing of opioids in the treatment of chronic pain, cliexa enables providers to remotely monitors opioid-prescribed patients while empowering them to relay their patient-reported outcomes and track their mental health conditions in association with their chronic pain, while catering specifically towards the individual needs of each patient-provider relationship.

Check out the cliexa mobile platform for Pain Management, cliexa-EASE: //www.cliexa.com/cliexamobile/pain-management/

3. Behavioral Health & Addiction Treatment

Though struggles with addiction are becoming increasingly more prevalent in society, the present methods of addiction treatment are limited. Through innovations in health technologies, patients and providers are shifting towards new ways of treating addiction. The monitoring of patients in real-time is essential for positive treatment outcomes for both patients and their providers. By leveraging patient-reported data, patients adhere to their treatment plans and overcome addiction as a disease, rather than as a fault.

Check out the cliexa mobile platform for Behavioral Health, cliexa-SENSE: //www.cliexa.com/cliexamobile/behavioral-health/

4. Digestive Health

Through cliexa innovations, providers better manage chronic gastrointestinal diseases, such as inflammatory bowel disease or ulcerative colitis, using specifically-designed, highly-structured treatment plans that leverage disease activity scoring models taken from qualitative patient responses to assessments which quantify and track symptoms over long periods of time.

Check out the cliexa mobile platform for Digestive Health, cliexa-IBD: //www.cliexa.com/cliexamobile/inflammatory-bowel-disease/

5. Respiratory Care

cliexa enables providers to qualitatively track chronic diseases of the respiratory system, like chronic obstructive pulmonary disease (COPD), through remote patient-reported outcomes. The ability to structure individualized and specialized care leads to improved patient-provider experiences.

Check out the cliexa mobile platform for Respiratory Care, cliexa-COPD: //www.cliexa.com/cliexamobile/chronic-obstructive-pulmonary-disease/

6. Pediatric Care

cliexa health technology drives innovations in mental health resiliency in adolescents, a hot topic in today’s health community. cliexa’s clinically validated medical assessment applications, coupled with its mHealth prevention services, help providers identify and reduce risk behaviors in adolescents and young adults. cliexa’s mobile patient-engagement applications equip providers with the tools adolescents use to overcome anxiety and depression, increasing the overall quality-of-care for both patients and providers.

Check out the cliexa mobile platform for Pediatric Care, cliexa-OPTIONS: //www.cliexa.com/cliexamobile/adolescent-resiliency/

cliexa® partners with the University of Colorado Boulder’s Cognitive and Affective Neuroscience Lab (CANLab) for Multidimensional Pain Tracking and Predictive Analytics Research.
cliexa® Partners with Institute of Cognitive Science at University of Colorado Boulder

Denver, CO, February 28, 2018 — cliexa, Inc., which offers a suite of mobile platforms for chronic disease management, announces its collaboration with CU Boulder’s CANLab and Institute of Cognitive Science (ICS). cliexa will collaborate with CANLab’s team, headed by Tor Wager, a professor of psychology and neuroscience, as they lead in multidimensional pain tracking and predictive analytics research.

CU Boulder jointly filed a provisional patent with cliexa for the multidimensional objective pain concept with CANLab. CANLab focuses on identifying a particular pattern of brain activity, which is diagnostic of physical pain. cliexa-Ease’s mobile platform hosts the research concept and is being used to further develop CANLab’s existing pain studies. cliexa-Ease will deliver an exclusive pain assessment model which, in collaboration with CU Boulder, anticipates commercialization by mid 2018.

Mehmet Kazgan, founder and CEO of cliexa, explains how they are excited about the partnership with Wager’s CANLab because of its “leading research studies for multidimensional pain tracking.” “Working with neuroscientists at CU Boulder is taking the cliexa platform to the next level of objectifying patient outputs with multiple reference points.”

Wager highlights how the collaboration will “expand our ability to understand how emotion affects pain in daily life.” Pavel Goldstein, the scientific lead of the project, adds that the partnership will provide both “an incredible opportunity to establish a platform for researching chronic pain conditions” and “important feedback to pain patients and their clinicians with unique information about patient health.”

About The Cognitive and Affective Neuroscience Lab

Professor Tor Wager leads CANLab, which is housed in CU Boulder’s Institute of Cognitive Science (ICS) and the Psychology and Neuroscience Department. CANLab uses machine-learning to develop fMRI-based biomarkers for clinically relevant outcomes, such as pain. It subsequently tests how psychological factors influence these biomarkers. The lab also engages in collaborative, translational research, which incorporates brain systems-level analyses into the study of clinical disorders, including PTSD, depression, schizophrenia, and chronic pain.

Learn more about CAN Lab at //canlabweb.colorado.edu

About cliexa
The mobile platform technology developed by cliexa enables patients to track their chronic disease activity by quantifying symptoms using scientifically-proven and clinically-validated scoring models. cliexa delivers quantified disease activity and medication adherence through patient reported outcomes through real-time integration to electronic medical records, which streamline processes and increase efficiency in population health management.

Learn more about cliexa at //www.cliexa.com

See the Press release here: